Skip to main content

Holiday schedule

Quest Diagnostics Patient Service Centers will have modified hours during the holiday season.

  • Closing early at 12:00pm on December 31, 2025
  • Closed on January 1, 2026


Have a healthy, happy holiday!

Hide
Quest Diagnostics

Post-induction Minimal Residual Disease Defined by Next-Generation Sequencing Predicts Poorer Clinical Outcomes in Patients with Acute Myeloid Leukemiag

2022  USCAP (United States and Canadian Academy of Pathology 112th Annual Meeting)

March 19-24, 2022, Los Angeles, CA

Poster presentation: Post-induction Minimal Residual Disease Defined by Next-Generation Sequencing Predicts Poorer Clinical Outcomes in Patients with Acute Myeloid Leukemiag

Authors: Li Y, Solis-Ruiz J, Tong CH,  Mohebnasab M,  Racke FK,  Lacbawan FL, Press R

Specialties: Oncology, Genetics

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.